METHODS FOR DETERMINING LIKELIHOOD OF SURVIVAL OF CANCER PATIENTS AND FOR PREDICTING LIKELIHOOD OF METASTASIS IN CANCER PATIENTS

• 1. 预测癌症患者的预后的方法、预测抗癌疗法的有效性的方法和选择适合癌症患者的疗法的方法 [P] . 中国专利： CN114096850A . 2022-02-25
• 2. 用于将癌症患者分类到合适的癌症治疗组的系统和方法以及治疗癌症患者的组合物 [P] . 中国专利： CN111670364A . 2020-09-15
• 3. Methods for determining the survival potential of cancer patients and predicting the likelihood of metastasis in cancer patients [P] . 日本专利： JP6626037B2 . 2019-12-25

  机译： 确定癌症患者生存潜力并预测癌症患者转移可能性的方法

• 4. Methods for determining the survival potential of cancer patients and for predicting the likelihood of metastasis in cancer patients [P] . 日本专利： JP6468838B2 . 2019-02-13

  机译： 确定癌症患者生存潜力和预测癌症患者转移可能性的方法

• 5. Methods for determining the survival potential of cancer patients and for predicting the likelihood of metastasis in cancer patients [P] . 日本专利： JP2014515477A . 2014-06-30

  机译： 确定癌症患者生存潜力和预测癌症患者转移可能性的方法

• 1. Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients [J] . Guo-Wen Lin, Guo-Hai Shi, Xiao-Jian Qin, 亚洲男性学杂志（英文版） . 2009,第004期
• 2. Prostate-specific antigen half-life： a new predictor of progression- free survival and overall survival in Chinese prostate cancer patients [J] . Guo-Wen Lin, Xu-Dong Yao, Shi-Lin Zhang, 亚洲男性学杂志：英文版 . 2009,第004期
• 3. Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer [J] . Lan He, Yanqi Huang, Lixu Yan, 中国癌症研究（英文版） . 2019,第004期
• 4. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis [J] . Tadafumi Asaoka, Atsushi Miyamoto, Sakae Maeda, 国际肝胆胰疾病杂志（英文版） . 2018,第001期
• 5. Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer [J] . Kang K. A., Jang K. M., Kim S. H., Clinical Radiology: Journal of the Royal College of Radiologists . 2017,第6期
• 6. Predictive Model for Likelihood of Survival among Breast Cancer Patients using MachineLearning Techniques [J] . Ajinaja Micheal Olalekan, Mobolaji Olarinde Asian Journal of Information Technology . 2020,第11期
• 7. Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a “PET biopsy” method [J] . Yizhao Xie, Bingxin Gu, Xichun Hu, Cancer Management and Research . 2019,第2期
• 8. Kernel Mixture Survival Models for Identifying Cancer Subtypes, Predicting Patients Cancer Types and Survival Probabilities [C] . Tomohiro Ando, Seiya Imoto, Satoru Miyano International Workshop on Bioinformatics and Systems Biology . 2004
• 9. Genetic variation and protein expression of metastasis-related genes as markers of tumor aggressiveness, recurrence, and survival among breast cancer patients. [D] . Roberts, Michelle R. 2016
• 10. Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a PET biopsy method [O] . Yizhao Xie, Bingxin Gu, Xichun Hu, 2019
• 11. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

• 1. Prognostic nomograms for predicting overall survival and causespecific survival of signet ring cell carcinoma in colorectal cancer patients [J] . Fu-Rong Kou ,Yang-Zi Zhang ,Wei-Ran Xu . 世界临床病例杂志 . 2021,第011期
• 2. CALM——晚期癌症患者安宁疗护的新方法 [C] . 尚美美 . 2017山东省心理卫生协会学术大会 . 2017
• 3. 癌症患者生活质量评价方法的构建 [A] . 张俊茹 . 2012